De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study-Reference-Cited by-同舟云学术

De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study

Published:2016-06-16 Issue:2 Volume:119 Page:261-267
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Lee Hakmin¹,Lee Sang Eun²,Byun Seok-Soo²,Kim Hyeon Hoe³,Kwak Cheol³,Hong Sung Kyu²

Affiliation:

1. Department of Urology; Samsung Medical Centre; Sungkyunkwan University School of Medicine; Seoul Korea

2. Department of Urology; Seoul National University Bundang Hospital; Seongnam-si Gyunggi-do Korea

3. Department of Urology; Seoul National University Hospital; Seoul Korea

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13545/fullpdf

Reference24 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention;Weikert;World J Urol,2010

3. EAU guidelines on renal cell carcinoma: the 2010 update;Ljungberg;Eur Urol,2010

4. Prognostic predictors in colorectal cancer;Lindmark;Dis Colon Rectum,1994

5. A report from the subcommittee for the management of lung cancer of the United Kingdom coordinating committee on cancer research;Rawson;Br J Cancer,1990

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth kinetics and predictive factors in renal angiomyolipomas;International Urology and Nephrology;2024-07-26

2. Alpha-L-fucosidase as a putative prognostic biomarker in breast cancer;The Ukrainian Biochemical Journal;2024-06-14

3. Clinical significance of pretreatment De Ritis ratio in renal cell carcinoma;Journal of Health Sciences and Medicine;2024-05-27

4. Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy;Cancers;2023-12-06

5. Prognostic Value of the De Ritis Ratio for Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radioligand Therapy;Cancers;2023-10-10